Novonesis Statistics
Want to see NVZMY full AI Analyst Report?
Novonesis (NVZMY) Stock Statistics & Valuation Metrics
Total Valuation
Novonesis has a market cap or net worth of $30.67B. The enterprise value is $32.76B.
- Market Cap
- $30.67B
- Enterprise Value
- $32.76B
Share Statistics
Novonesis has 414,555,050 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 414,555,050
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
Novonesis’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 4.57%.
- Return on Equity (ROE)
- 0.05
- Return on Assets (ROA)
- 0.04
- Return on Invested Capital (ROIC)
- 4.57%
- Return on Capital Employed (ROCE)
- 0.06
- Revenue Per Employee
- 357.15K
- Profits Per Employee
- 50.13K
- Employee Count
- 11,641
- Asset Turnover
- 0.25
- Inventory Turnover
- 2.48
Valuation Ratios
The current PE Ratio of Novonesis is 39.26. Novonesis’s PEG ratio is 1.45.
- PE Ratio
- 39.26
- PS Ratio
- 5.56
- PB Ratio
- 2.47
- Price to FCF
- 35.08
- Price to Operating Cash Flow
- 22.56
- PEG Ratio
- 1.45
Income Statement
In the last 12 months, Novonesis had revenue of 4.16B and earned 583.60M in profits. Earnings per share was 1.35.
- Revenue
- 4.16B
- Gross Profit
- 2.24B
- Operating Income
- 882.60M
- Pretax Income
- 743.40M
- Net Income
- 583.60M
- EBITDA
- 1.39B
- Earnings Per Share (EPS)
- 1.35
Cash Flow
In the last 12 months, operating cash flow was 1.24B and capital expenditures -537.06M, giving a free cash flow of 699.76M billion.
- Operating Cash Flow
- 1.24B
- Free Cash Flow
- 699.76M
- Free Cash Flow per Share
- 1.47
Dividends & Yields
Novonesis pays an annual dividend of $0.10, resulting in a dividend yield of 0.24%
- Dividend Per Share
- $0.10
- Dividend Yield
- 0.24%
- Payout Ratio
- 21.81%
- Free Cash Flow Yield
- 2.85%
- Earnings Yield
- 2.46%
Stock Price Statistics
- Beta
- 0.06
- 52-Week Price Change
- 2.95%
- 50-Day Moving Average
- 67.44
- 200-Day Moving Average
- 62.43
- Relative Strength Index (RSI)
- 40.89
- Average Volume (3m)
- 27.55K
Important Dates
Novonesis upcoming earnings date is Feb 11, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Feb 11, 2027
- Ex-Dividend Date
- Mar 25, 2026
Financial Position
Novonesis as a current ratio of 0.72, with Debt / Equity ratio of 206.77%
- Current Ratio
- 0.72
- Quick Ratio
- 0.44
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- 15.99
- Interest Coverage Ratio
- 96.59
Taxes
In the past 12 months, Novonesis has paid 153.49M in taxes.
- Income Tax
- 153.49M
- Effective Tax Rate
- 0.21
Enterprise Valuation
Novonesis EV to EBITDA ratio is 21.56, with an EV/FCF ratio of 38.30.
- EV to Sales
- 6.07
- EV to EBITDA
- 21.56
- EV to Free Cash Flow
- 38.30
- EV to Operating Cash Flow
- 21.64
Balance Sheet
Novonesis has $465.50M in cash and marketable securities with $2.69B in debt, giving a net cash position of -$2.22B billion.
- Cash & Marketable Securities
- $465.50M
- Total Debt
- $2.69B
- Net Cash
- -$2.22B
- Net Cash Per Share
- -$5.37
- Tangible Book Value Per Share
- $0.36
Margins
Gross margin is 56.31%, with operating margin of 22.80%, and net profit margin of 15.59%.
- Gross Margin
- 56.31%
- Operating Margin
- 22.80%
- Pretax Margin
- 19.98%
- Net Profit Margin
- 15.59%
- EBITDA Margin
- 28.15%
- EBIT Margin
- 21.12%
Analyst Forecast
The average price target for Novonesis is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 10.90%
- EPS Growth Forecast
- 30.98%
Scores
- Smart Score
- 6
- AI Score
- 63

